DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Oct. 31, 2021

Derivative Financial Instruments [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The following table summarizes the fair value and presentation of the Company’s derivative financial instruments in its Consolidated Balance Sheets:

	Assets												Liabilities
	10/31/21				1/31/21				11/1/20				10/31/21				1/31/21				11/1/20
(In millions)	Other Current Assets		Other Assets		Other Current Assets		Other Assets		Other Current Assets		Other Assets		Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities
Contracts designated as cash flow hedges:
Foreign currency forward exchange contracts (inventory purchases)	$	25.1	$	1.3	$	1.2	$	0.1	$	6.4	$	1.0	$	1.4	$	0.1	$	29.0	$	0.4	$	11.3	$	0.1
Interest rate swap agreements	—		—		—		—		—		—		0.3		—		3.2		1.5		5.6		2.0
Total contracts designated as cash flow hedges	25.1		1.3		1.2		0.1		6.4		1.0		1.7		0.1		32.2		1.9		16.9		2.1
Undesignated contracts:
Foreign currency forward exchange contracts	3.4		—		2.5		—		3.5		—		2.1		—		1.6		—		2.3		—
Interest rate swap agreements	—		—		—		—		—		—		0.5		0.1		—		—		—		—
Total undesignated contracts	3.4		—		2.5		—		3.5		—		2.6		0.1		1.6		—		2.3		—
Total	$	28.5	$	1.3	$	3.7	$	0.1	$	9.9	$	1.0	$	4.3	$	0.2	$	33.8	$	1.9	$	19.2	$	2.1

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

The following tables summarize the effect of the Company’s hedges designated as cash flow and net investment hedging instruments:

	Gain (Loss) Recognized in Other Comprehensive (Loss) Income
(In millions)
Thirteen Weeks Ended	10/31/21		11/1/20
Foreign currency forward exchange contracts (inventory purchases)	$	17.2	$	13.1
Interest rate swap agreements	0.1		0.3
Foreign currency borrowings (net investment hedges)	27.4		16.7
Total	$	44.7	$	30.1
Thirty-Nine Weeks Ended	10/31/21		11/1/20
Foreign currency forward exchange contracts (inventory purchases)	$	82.0	$	(23.0)
Interest rate swap agreements	0.2		(9.7)
Foreign currency borrowings (net investment hedges)	54.7		(76.2)
Total	$	136.9	$	(108.9)

	Amount of (Loss) Gain Reclassified from AOCL into (Expense) Income, Consolidated Statements of Operations Location, and Total Amount of Consolidated Statements of Operations Line Item
(In millions)	Amount Reclassified				Location	Total Statements of Operations Amount
Thirteen Weeks Ended	10/31/21		11/1/20			10/31/21		11/1/20
Foreign currency forward exchange contracts (inventory purchases)	$	(6.6)	$	5.3	Cost of goods sold	$	987.4	$	1,016.8
Interest rate swap agreements	(1.3)		—		SG&A (1)	1,097.3		987.2
Interest rate swap agreements	(0.7)		(3.3)		Interest expense	25.9		34.4
Total	$	(8.6)	$	2.0
Thirty-Nine Weeks Ended	10/31/21		11/1/20			10/31/21		11/1/20
Foreign currency forward exchange contracts (inventory purchases)	$	1.2	$	8.4	Cost of goods sold	$	2,817.2	$	2,392.3
Interest rate swap agreements	(1.3)		—		SG&A (1)	3,198.7		2,809.5
Interest rate swap agreements	(2.6)		(7.9)		Interest expense	83.7		89.6
Total	$	(2.7)	$	0.5

(1) The Company dedesignated certain cash flow hedges related to its interest rate swap agreements during the thirteen weeks ended October 31, 2021 as discussed in the section entitled “Cash Flow Hedges” above.

Derivatives Not Designated as Hedging Instruments [Table Text Block]

The following table summarizes the effect of the Company’s undesignated contracts recognized in SG&A expenses in its Consolidated Statements of Operations:

(In millions)	(Loss) Gain Recognized in (Expense) Income
Thirteen Weeks Ended	10/31/21		11/1/20
Foreign currency forward exchange contracts	$	(4.7)	$	2.0
Thirty-Nine Weeks Ended	10/31/21		11/1/20
Foreign currency forward exchange contracts	$	(6.9)	$	(2.1)

The Company dedesignated certain cash flow hedges related to its interest rate swap agreements during the thirteen weeks ended October 31, 2021 as discussed in the section entitled “Cash Flow Hedges” above. Following the dedesignation, the effect of these interest rate swap agreements recognized in SG&A expenses in the Company’s Consolidated Statements of Operations was immaterial for the thirteen weeks ended October 31, 2021.